A Dose of Change
Tags: SHARER, Kevin -- Interviews; AMGEN Inc.; CHIEF executive officers; MANAGEMENT styles
Related Articles
- Making Big Drugs. Colvin, Geoff // Fortune International (Asia);7/20/2009, Vol. 160 Issue 2, p31
An interview with Amgen chief executive officer (CEO) Kevin Sharer is presented. He discusses the impact of the health care reform program of U.S. President Barack Obama focused on cost reduction on many Amgen drugs which are very expensive. He claims that he favors private sector over public...
- Making Big Drugs. Colvin, Geoff // Fortune International (Europe);7/20/2009, Vol. 160 Issue 2, p100
An interview with pharmaceutical company Amgen chief executive officer (CEO) Kevin Sharer is presented. Sharer comments on U.S. President Barack Obama's plans for health-care reform and cost reduction and whether that will be a problem for Amgen's expensive drugs. He comments on whether he...
- Making Big Drugs. Colvin, Geoff // Fortune;7/20/2009, Vol. 160 Issue 2, p31
An interview with pharmaceutical company Amgen chief executive officer (CEO) Kevin Sharer is presented. Sharer comments on U.S. President Barack Obama's plans for health-care reform and cost reduction and whether that will be a problem for Amgen's expensive drugs. He comments on whether he...
- 'The Reward for Innovation is VERY, VERY High.'. Sharer, Kevin // American (19328117);Mar/Apr2007, Vol. 1 Issue 3, p90
An interview with Kevin Sharer, chief executive office (CEO) of Amgen based in Thousand Oaks, California, is presented. The CEO is worried about the protection that biopharmaceuticals get from the government against threats to intellectual property from abroad. Sharer presents comments on the...
- From Biotech to Big Pharma. Koberstein, Wayne // Pharmaceutical Executive;May2000, Vol. 20 Issue 5, p46
Features Gordon Binder, chairman and chief executive officer of Amgen, a pharmaceutical company in the United States. Background information on the company; His contributions to the company; Expansion plans for Amgen; Information on the company's `small-molecule' discovery and development...
- LLOYD FORD. Gardner, Elizabeth // Modern Healthcare;9/17/2007, Vol. 37 Issue 37, p25
The article focuses on the professional career of Lloyd Ford, chief executive officer of Muhlenberg Community Hospital in Greenville, Kentucky. When he assumed his position in the hospital, the organization had a history of five straight years of losses and there was a feud between one group of...
- YES, BOSS. Hatfield, John // Accountancy;Nov98, Vol. 122 Issue 1263, p52
The article explains that the arrival of a new chief executive officer (CEO) is a cultural revolution and it can involve re-education for the employees. Employees should find out whether he is a disciple of total quality, an adherent of management by objectives or walking around, an espouser of...
- MANAGING WITH STYLE: THE EFFECT OF MANAGERS ON FIRM POLICIES. Bertrand, Marianne; Schoar, Antoinette // Quarterly Journal of Economics;Nov2003, Vol. 118 Issue 4, p1169
This paper investigates whether and how individual managers affect corporate behavior and performance. We construct a manager-firm matched panel data set which enables us to track the top managers across different firms over time. We find that manager fixed effects matter for a wide range of...
- George Hickton. Robinson, Jim // New Zealand Management;Jul2003, Vol. 50 Issue 6, p34
Discusses the influence of the personal management style and strategic thinking of George Hickton, chief executive of Tourism New Zealand, on the tourism industry's growth. Changes administered by Hickton; Keys for successfully implementing the changes; His prediction for the industry. INSET:...
